• Skip to main content
  • Skip to secondary menu
  • Skip to primary sidebar
  • Skip to secondary sidebar
  • Skip to footer

  • Opinion
  • Health IT
    • Behavioral Health
    • Care Coordination
    • EMR/EHR
    • Interoperability
    • Patient Engagement
    • Population Health Management
    • Revenue Cycle Management
    • Social Determinants of Health
  • Digital Health
    • AI
    • Blockchain
    • Precision Medicine
    • Telehealth
    • Wearables
  • Startups
  • M&A
  • Value-based Care
    • Accountable Care (ACOs)
    • Medicare Advantage
  • Life Sciences
  • Research

Sentara Health Taps RhythmX AI to Deploy Generative AI-Driven Co-Pilot for Clinicians

by Syed Hamza Sohail 02/22/2024 Leave a Comment

  • LinkedIn
  • Twitter
  • Facebook
  • Email
  • Print

What You Should Know:

  • RhythmX AI, a generative AI-native company driving revolutionary physician intelligence for whole-person care through cutting edge predictive and generative AI, announced a strategic partnership with Virginia-based Sentara Health, one of the top 20 largest not-for-profit integrated health care delivery systems in the country. 
  • Together, RhythmX AI and Sentara are building the next generation of hyper-personalized primary care for clinicians and patients. 

Revolutionizing Primary Care: Enhancing Clinician Decision-Making with RhythmX AI at Sentara

Utilizing RhythmX AI’s state-of-the-art predictive and generative AI platform, Sentara’s primary care clinicians will gain access to the most relevant clinical and payer guidelines, facilitating earlier disease detection, in-depth analysis of EMR data, and assistance with documentation. Essentially, the platform will provide clinicians with precise, pertinent information at the point of care, allowing them to dedicate more time to meaningful interactions with patients during clinic visits and execute all necessary actions efficiently.

In the envisioned future, RhythmX AI and Sentara aspire to see all primary care team members, including PCPs, APPs, and RNs, leveraging the same advanced intelligence platform to guide them with next best clinical actions derived directly from pertinent clinical and payer guidelines. This vision encompasses a commitment to team-based, high-quality care, ensuring that patients, regardless of where they access Sentara primary care services—be it same-day walk-in clinics, urgent care facilities, or traditional primary care offices—receive top-notch care and personalized treatment plans tailored to their individual needs.

“Our vision is to infuse personalized clinical intelligence into every visit and treatment so that physicians can deliver more personalized care while returning the joy of practice,” said Dr. Jordan Asher, MD, MS, Executive Vice President and Chief Clinical Officer for Sentara. “Sentara and RhythmX AI’s joint vision is an important part of the future where all clinicians are seeing hyper-personalized intervention recommendations based on clinical, social determinants of health, mental health, and lifestyle aspects of patients that treat both the physiologic dynamics of their clinical condition and their diseases of life.” 

  • LinkedIn
  • Twitter
  • Facebook
  • Email
  • Print

Tagged With: Artificial Intelligence, Generative AI

Tap Native

Get in-depth healthcare technology analysis and commentary delivered straight to your email weekly

Reader Interactions

Primary Sidebar

Subscribe to HIT Consultant

Latest insightful articles delivered straight to your inbox weekly.

Submit a Tip or Pitch

Featured Insights

2025 EMR Software Pricing Guide

2025 EMR Software Pricing Guide

Featured Interview

Paradigm Shift in Diabetes Care with Studio Clinics: Q&A with Reach7 Founder Chun Yong

Most-Read

Medtronic to Separate Diabetes Business into New Standalone Company

Medtronic to Separate Diabetes Business into New Standalone Company

White House, IBM Partner to Fight COVID-19 Using Supercomputers

HHS Sets Pricing Targets for Trump’s EO on Most-Favored-Nation Drug Pricing

23andMe to Mine Genetic Data for Drug Discovery

Regeneron to Acquire Key 23andMe Assets for $256M, Pledges Continuity of Consumer Genome Services

CureIS Healthcare Sues Epic: Alleges Anti-Competitive Practices & Trade Secret Theft

The Evolving Role of Physician Advisors: Bridging the Gap Between Clinicians and Administrators

The Evolving Physician Advisor: From UM to Value-Based Care & AI

UnitedHealth Group Names Stephen Hemsley CEO as Andrew Witty Steps Down

UnitedHealth CEO Andrew Witty Steps Down, Stephen Hemsley Returns as CEO

Omada Health Files for IPO

Omada Health Files for IPO

Blue Cross Blue Shield of Massachusetts Launches "CloseKnit" Virtual-First Primary Care Option

Blue Cross Blue Shield of Massachusetts Launches “CloseKnit” Virtual-First Primary Care Option

Osteoboost Launches First FDA-Cleared Prescription Wearable Nationwide to Combat Low Bone Density

Osteoboost Launches First FDA-Cleared Prescription Wearable Nationwide to Combat Low Bone Density

2019 MedTech Breakthrough Award Category Winners Announced

MedTech Breakthrough Announces 2025 MedTech Breakthrough Award Winners

Secondary Sidebar

Footer

Company

  • About Us
  • Advertise with Us
  • Reprints and Permissions
  • Submit An Op-Ed
  • Contact
  • Subscribe

Editorial Coverage

  • Opinion
  • Health IT
    • Care Coordination
    • EMR/EHR
    • Interoperability
    • Population Health Management
    • Revenue Cycle Management
  • Digital Health
    • Artificial Intelligence
    • Blockchain Tech
    • Precision Medicine
    • Telehealth
    • Wearables
  • Startups
  • Value-Based Care
    • Accountable Care
    • Medicare Advantage

Connect

Subscribe to HIT Consultant Media

Latest insightful articles delivered straight to your inbox weekly

Copyright © 2025. HIT Consultant Media. All Rights Reserved. Privacy Policy |